首页> 外国专利> Method of treating thrombosis in a mammal, and using a combination of (i) a factor xa inhibitor, and (ii) a compound selected from the group consisting of aspirin, tpa, a gpiib / iiia antagonist, low weight heparin molecular and heparin

Method of treating thrombosis in a mammal, and using a combination of (i) a factor xa inhibitor, and (ii) a compound selected from the group consisting of aspirin, tpa, a gpiib / iiia antagonist, low weight heparin molecular and heparin

机译:治疗哺乳动物中血栓形成的方法,并结合使用(i)因子xa抑制剂和(ii)选自阿司匹林,tpa,gpiib / iiia拮抗剂,低重量肝素分子和肝素的化合物

摘要

"METHOD OF TREATING THROMBOSIS IN A MAMMALIAN, AND USE OF A COMBINATION OF (I) A FACTOR XA INHIBITOR, AND (II) A SELECTED COMPOSITION OF THE GROUP THAT CONSISTS OF ASPIRIN, TPA, A GPIIB / IIIA ANTAGONIST, LOW HEPARINE MOLECULAR WEIGHT AND HEPARIN ". It is a method of treating thrombosis in mammals by administering therapeutically effective amounts of a combination of (i) a factor Xa inhibitor, and (ii) a compound selected from the group consisting of aspirin, a GPIIb / antagonist IIIa, low molecular weight heparin and heparin, and the dose administered to at least one of (i) and (ii) is a subtherapeutic dose. Preferably, the combination of (i) and (ii) provides a synergistic effect.
机译:“治疗哺乳动物血栓形成的方法,以及(I)因子XA抑制剂的组合使用,以及(II)由阿司匹林,TPA,GPIIB / IIIA拮抗剂,肝素低分子量组成的组的选定组成和肝素”。它是通过治疗有效量的(i)Xa因子抑制剂和(ii)选自阿司匹林,GPIIb /拮抗剂IIIa,低分子量肝素的组合治疗哺乳动物中的血栓形成的方法(i)和(ii)中至少一项的剂量为亚治疗剂量。优选地,(i)和(ii)的组合提供协同作用。

著录项

  • 公开/公告号BR0010381A

    专利类型

  • 公开/公告日2002-02-05

    原文格式PDF

  • 申请/专利权人 DU PONT PHARMACEUTICALS COMPANY;

    申请/专利号BR20000010381

  • 发明设计人 PANCRAS C. WONG;

    申请日2000-03-10

  • 分类号A61P7/02;A61P9/12;A61K31/715;A61K45/06;A61K38/49;A61K38/02;A61K31/42;A61K31/60;

  • 国家 BR

  • 入库时间 2022-08-22 00:46:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号